None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Aged 19 years or order 2) Persistent high-risk HPV infection of the cervix and vagina confirmed by two positive results at 3-month intervlas 3) Those who voluntarily agreed to participate in this clinical study and to provide written informed conset
Exclusion criteria
Exclusion criteria: 1) Those who are pregnant 2) Participants who are unable to maintain the lithotomy position 3) Other cases where participation in this clinical study is deemed unsuitable at the discretion of the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of participants with a semi-quantitative reduction in HPV PCR levels | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of participants with a semi-quantitative reduction in HPV PCR levels;Proportion of participants with conversion to HPV PCR negativity;Proportion of participants with conversion to HPV PCR negativity;Changes in PCR test results for 12 STIs;Adverse events / Serious adverse events | — |
Countries
Korea, Republic of
Contacts
Hanyang University Guri Hospital